[HTML][HTML] Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19: a systematic review and meta-analysis without cases …
Z Wang, H Deng, C Ou, J Liang, Y Wang, M Jiang, S Li - Medicine, 2020 - journals.lww.com
Background: The pandemic of COVID-19 poses a challenge to global healthcare. The mortality
rates of severe cases range from 8.1% to 38%, and it is particularly important to identify …
rates of severe cases range from 8.1% to 38%, and it is particularly important to identify …
[HTML][HTML] Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
…, YY Huang, Y Shi, Y Xu, H Xian, F Bai, C Ou… - … Pharmaceutica Sinica B, 2020 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause acute
respiratory distress syndrome, hypercoagulability, hypertension, and multiorgan dysfunction. …
respiratory distress syndrome, hypercoagulability, hypertension, and multiorgan dysfunction. …
Therapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunction
…, J Wang, Y Shi, Y Xu, H Xian, R Fang, F Bai, C Ou… - MedRxiv, 2020 - medrxiv.org
The human coronavirus HCoV-19 infection can cause acute respiratory distress syndrome (ARDS),
hypercoagulability, hypertension, extrapulmonary multiorgan dysfunction. Effective …
hypercoagulability, hypertension, extrapulmonary multiorgan dysfunction. Effective …
[HTML][HTML] TSSK4 upregulation in alveolar epithelial type-II cells facilitates pulmonary fibrosis through HSP90-AKT signaling restriction and AT-II apoptosis
…, Y Huang, J Chen, J Guan, Q He, J Ma, C Ou… - Cell Death & …, 2021 - nature.com
Alveolar epithelial injury is one of the important pathological changes in idiopathic pulmonary
interstitial fibrosis (IPF), but the regulatory mechanism remains unclear. Here, we reported …
interstitial fibrosis (IPF), but the regulatory mechanism remains unclear. Here, we reported …
[HTML][HTML] Serum proteomic analysis identifies SAA1, FGA, SAP, and CETP as new biomarkers for eosinophilic granulomatosis with polyangiitis
…, M Liang, C Dong, X Zhang, M Qiu, C Ou… - Frontiers in …, 2022 - frontiersin.org
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is characterized by
asthma-like attacks in its early stage, which is easily misdiagnosed as severe asthma. Therefore, …
asthma-like attacks in its early stage, which is easily misdiagnosed as severe asthma. Therefore, …
[HTML][HTML] Machine learning models for predicting critical illness risk in hospitalized patients with COVID-19 pneumonia
…, L Lai, W Le, J Li, T Xia, X Zhang, C Ou… - Journal of thoracic …, 2021 - ncbi.nlm.nih.gov
Background To develop machine learning classifiers at admission for predicting which patients
with coronavirus disease 2019 (COVID-19) who will progress to critical illness. Methods …
with coronavirus disease 2019 (COVID-19) who will progress to critical illness. Methods …
[HTML][HTML] Lonicerin attenuates house dust mite-induced eosinophilic asthma through targeting Src/EGFR signaling
…, X Zhang, J Wen, X Yang, L Xue, C Ou… - Frontiers in …, 2022 - frontiersin.org
Eosinophilic asthma is the predominant phenotype of asthma, and although these patients
are sensitive to glucocorticoid therapy, they also experience many side effects. Lonicerin is a …
are sensitive to glucocorticoid therapy, they also experience many side effects. Lonicerin is a …
[HTML][HTML] CT quantification of COVID-19 pneumonia at admission can predict progression to critical illness: a retrospective multicenter cohort study
…, P Wu, T Xia, X Zhang, W Le, J Li, L Lai, C Ou… - Frontiers in …, 2021 - frontiersin.org
Objective: Early identification of coronavirus disease 2019 (COVID-19) patients with worse
outcomes may benefit clinical management of patients. We aimed to quantify pneumonia …
outcomes may benefit clinical management of patients. We aimed to quantify pneumonia …
[HTML][HTML] Serum cytokine profiling identifies axl as a new biomarker candidate for active eosinophilic granulomatosis with polyangiitis
J Ma, C Dong, S Wei, M Qiu, P Wu, C Ou… - Frontiers in Molecular …, 2021 - frontiersin.org
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) prognosis is generally
favorable and is treated with combined corticosteroids/immunosuppressor(s) therapy. However…
favorable and is treated with combined corticosteroids/immunosuppressor(s) therapy. However…
Selective eosinophil necroptosis contributes to airway inflammation and remodeling in asthma.
…, H Xie, H Chen, Y Wen, Q Chen, S Xie, H Li, C Ou… - Allergy, 2022 - search.ebscohost.com
To investigate the role of eosinophil necroptosis in asthma, we adoptively transferred
eosinophils to the airways of OVA/CFA-induced mice (Figure S2A). Abbreviation BALF …
eosinophils to the airways of OVA/CFA-induced mice (Figure S2A). Abbreviation BALF …